392 related articles for article (PubMed ID: 30619112)
1.
Deng H; Yang S; Zhang Y; Qian K; Zhang Z; Liu Y; Wang Y; Bai Y; Fan H; Zhao X; Zhi F
Front Microbiol; 2018; 9():2976. PubMed ID: 30619112
[No Abstract] [Full Text] [Related]
2. Corrigendum:
Deng H; Yang S; Zhang Y; Qian K; Zhang Z; Liu Y; Wang Y; Bai Y; Fan H; Zhao X; Zhi F
Front Microbiol; 2019; 10():601. PubMed ID: 31001213
[TBL] [Abstract][Full Text] [Related]
3. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism.
Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ
J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000
[TBL] [Abstract][Full Text] [Related]
4. Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon.
Moura IB; Buckley AM; Ewin D; Shearman S; Clark E; Wilcox MH; Chilton CH
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455242
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.
Schubert AM; Sinani H; Schloss PD
mBio; 2015 Jul; 6(4):e00974. PubMed ID: 26173701
[TBL] [Abstract][Full Text] [Related]
6. Pre-colonization with the commensal fungus Candida albicans reduces murine susceptibility to Clostridium difficile infection.
Markey L; Shaban L; Green ER; Lemon KP; Mecsas J; Kumamoto CA
Gut Microbes; 2018 Nov; 9(6):497-509. PubMed ID: 29667487
[TBL] [Abstract][Full Text] [Related]
7. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
[TBL] [Abstract][Full Text] [Related]
8. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
9.
Wu Z; Xu Q; Gu S; Chen Y; Lv L; Zheng B; Wang Q; Wang K; Wang S; Xia J; Yang L; Bian X; Jiang X; Zheng L; Li L
Front Microbiol; 2022; 13():841920. PubMed ID: 35663882
[No Abstract] [Full Text] [Related]
10. The Bacterial Gut Microbiota of Adult Patients Infected, Colonized or Noncolonized by
Crobach MJT; Ducarmon QR; Terveer EM; Harmanus C; Sanders IMJG; Verduin KM; Kuijper EJ; Zwittink RD
Microorganisms; 2020 May; 8(5):. PubMed ID: 32384826
[No Abstract] [Full Text] [Related]
11.
Zhang W; Zhu B; Xu J; Liu Y; Qiu E; Li Z; Li Z; He Y; Zhou H; Bai Y; Zhi F
Front Immunol; 2018; 9():1040. PubMed ID: 29868005
[TBL] [Abstract][Full Text] [Related]
12. A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity.
Gebhart D; Lok S; Clare S; Tomas M; Stares M; Scholl D; Donskey CJ; Lawley TD; Govoni GR
mBio; 2015 Mar; 6(2):. PubMed ID: 25805733
[TBL] [Abstract][Full Text] [Related]
13. The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with
Džunková M; D'Auria G; Xu H; Huang J; Duan Y; Moya A; Kelly CP; Chen X
Front Cell Infect Microbiol; 2016; 6():119. PubMed ID: 27757389
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of NVB302 versus vancomycin activity in an in vitro human gut model of Clostridium difficile infection.
Crowther GS; Baines SD; Todhunter SL; Freeman J; Chilton CH; Wilcox MH
J Antimicrob Chemother; 2013 Jan; 68(1):168-76. PubMed ID: 22966180
[TBL] [Abstract][Full Text] [Related]
15. Protective Effect of
Xu Q; Gu S; Chen Y; Quan J; Lv L; Chen D; Zheng B; Xu L; Li L
Front Microbiol; 2018; 9():2396. PubMed ID: 30356740
[No Abstract] [Full Text] [Related]
16. Quantitative characterization of Clostridioides difficile population in the gut microbiome of patients with C. difficile infection and their association with clinical factors.
Kim J; Cho Y; Seo MR; Bae MH; Kim B; Rho M; Pai H
Sci Rep; 2020 Oct; 10(1):17608. PubMed ID: 33077744
[TBL] [Abstract][Full Text] [Related]
17. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
Schubert AM; Rogers MA; Ring C; Mogle J; Petrosino JP; Young VB; Aronoff DM; Schloss PD
mBio; 2014 May; 5(3):e01021-14. PubMed ID: 24803517
[TBL] [Abstract][Full Text] [Related]
18. Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against
Murphy CK; O'Donnell MM; Hegarty JW; Schulz S; Hill C; Ross RP; Rea MC; Farquhar R; Chesnel L
World J Gastrointest Pathophysiol; 2023 Aug; 14(4):71-85. PubMed ID: 37727283
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vancomycin extended-dosing regimens for treatment of simulated Clostridium difficile infection within an in vitro human gut model.
Crowther GS; Chilton CH; Longshaw C; Todhunter SL; Ewin D; Vernon J; Karas A; Wilcox MH
J Antimicrob Chemother; 2016 Apr; 71(4):986-91. PubMed ID: 26755495
[TBL] [Abstract][Full Text] [Related]
20. The Gut Microbiota Is Associated with Clearance of Clostridium difficile Infection Independent of Adaptive Immunity.
Leslie JL; Vendrov KC; Jenior ML; Young VB
mSphere; 2019 Jan; 4(1):. PubMed ID: 30700514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
